Introduction Carbiogene Therapeutics Co. Ltd. is a high-tech biomedical innovation enterprise jointly founded by well-known scientists at home and abroad, integrating research and development, production and sales. It is a "5050 plan" enterprise and a national high-tech enterprise introduced by the Zhejiang Government of China.
Carbiogene Therapeutics has established an industry pattern with new anti-tumor immunotherapy products (new generation CAR-T, AI CAR-T, CAR-NK) as the leading, retroviral vector technology platform, new DC vaccine, immune cell and stem cell biological resource bank, medical laboratory center and digital medical health platform. The company is committed to promoting the clinical application of a new generation of tumor immune precision therapy technology. |